Actuate Therapeutics, Inc. Common stock (ACTU) Stock price, Description, News & Info

#ThinkSabio Latest News

Actuate Therapeutics Highlights Significant and Sustained Survival Benefit in Key Metastatic Pancreatic Cancer Patient Populations in Phase 2 Elraglusib Trial

Light
Dark